Latest Research in Single-cell and spatial transcriptomics
34 research papers · 2026 median publication year
Top Research Topics in Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics — 4 papers
- Esophageal Cancer Research and Treatment — 3 papers
- Cancer Immunotherapy and Biomarkers — 3 papers
- Cytokine Signaling Pathways and Interactions — 2 papers
- Bladder and Urothelial Cancer Treatments — 2 papers
- Ferroptosis and cancer prognosis — 2 papers
- Cancer Cells and Metastasis — 2 papers
- Neuroblastoma Research and Treatments — 1 papers
- Protein Degradation and Inhibitors — 1 papers
- Cancer, Stress, Anesthesia, and Immune Response — 1 papers
Highest-Cited Papers
- Multidimensional analysis on the potential of cell cycle-related gene STMN1 as a tumor biomarker
- CGP60474, a novel MITD1-targeted inhibitor for bladder cancer progression via CDK4/cyclin D1 pathway modulation
- Beyond Tumor-Intrinsic STAT3: Integrating Metabolic and Immune Communication in the Tumor Microenvironment of Cervical, Ovarian, and Endometrial Cancers
- Targeting endothelial CYP3A5 in lung adenocarcinoma remodels the immunosuppressive microenvironment via VEGF inhibition: Mechanistic insights from Diosmetin
- PTK6 inhibition by tilfrinib hinders the proliferation and migration of ovarian cancer cells
- p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer
- Identification of molecular subtypes and prognostic models for head and neck squamous cell carcinomas based on PFKFB4
- Subtype-Specific Prognostic and Molecular Significance of ADGRD1 in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
- Pro-inflammatory and autophagic pathways in lung cancer: dysregulation of key genes ADINR, C/EBPα, CHAST, ATG5, IL-1B, and DICER1-AS1
- FABP4 characterizes metabolic–immune interactions and serves as a prognostic biomarker across gynecologic malignancies: a multi-omics integrative analysis
- Integrated single-cell and bulk transcriptomic analysis reveals an epithelial cell-derived prognostic and immunotherapeutic signature with ADAM12 as a key functional regulator in non-small cell lung cancer
- The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair
- Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma
- Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Associated with Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic Study
- Detection of a mosaic DNMT3A variant with potential neurodevelopmental and malignancy risks in monozygotic twins: a case report
- Genotype‐Informed Whole‐Animal Kinome Screening Reveals Shared Kinase Vulnerabilities Across Driver Contexts in PDAC
- Dissecting the myeloid cell-driven ecosystems through multi-omics and heterogeneous graph learning in pancreatic ductal adenocarcinoma
- Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer
- Immunity-Related Gene Characterization and Targeted Therapy in Lung Cancer: A Data Mining Approach to Predicting Immunotherapy Response
- MYSM1 suppresses cervical cancer progression by triggering ITPR1-mediated autophagy